Education
About Us
Working with TipRanks
Follow Us
Option Care Health (OPCH)
NASDAQ:OPCH
OPCH Stock Chart & Stats
$34.75
-$0.14(-0.58%)
At close: 4:00 PM EST
$34.75
-$0.14(-0.58%)
Day’s Range― - ―
52-Week Range$24.24 - $35.54
Previous CloseN/A
Volume256.90K
Average Volume (3M)1.73M
Market Cap
$5.64B
Enterprise Value$5.49B
Total Cash (Recent Filing)$309.82M
Total Debt (Recent Filing)$1.28B
Price to Earnings (P/E)28.2
Beta0.33
Next Earnings
Feb 19, 2026EPS Estimate
0.47Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.45
Shares Outstanding158,732,710
10 Day Avg. Volume1,586,582
30 Day Avg. Volume1,729,261
Financial Highlights & Ratios
PEG Ratio-1.08
Price to Book (P/B)2.83
Price to Sales (P/S)0.80
P/FCF Ratio13.83
Enterprise Value/Market Cap0.97
Enterprise Value/Revenue0.99
Enterprise Value/Gross Profit5.12
Enterprise Value/Ebitda11.93
Forecast
1Y Price Target
$37.00Price Target Upside6.47% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering10
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Capital Returns And BuybacksExpanded share repurchase authorization increases capacity for buybacks and signals management confidence in cash generation, which can help underpin shareholder value.
Long-term Demand DriversAging demographics and a shift toward lower-cost, home and alternate-site care are expected to sustain demand for the company's infusion services, supporting longer-term revenue expansion.
Scale And Market Share GainsA scaled network and evolving alternative-site care model enable market share gains in acute and chronic therapies, supporting faster top-line growth and EBITDA leverage.
Bears Say
Forecast And Guidance UncertaintyLack of clear guardrails around the magnitude and duration of biosimilar adoption and policy-driven price changes leaves investors with elevated uncertainty about future earnings and valuation.
Pricing And Policy PressurePricing pressure from biosimilars and Inflation Reduction Act–driven price cuts could reduce gross profits and compress margins, creating headwinds for earnings.
Product Concentration RiskEarnings exposure to a key branded therapy could materially reduce revenue and delay a return to long-term double-digit EBITDA growth if market share or pricing declines.
Option Care Health News
OPCH FAQ
What was Option Care Health’s price range in the past 12 months?
Option Care Health lowest stock price was $24.23 and its highest was $35.54 in the past 12 months.
What is Option Care Health’s market cap?
Option Care Health’s market cap is $5.64B.
When is Option Care Health’s upcoming earnings report date?
Option Care Health’s upcoming earnings report date is Feb 19, 2026 which is in 35 days.
How were Option Care Health’s earnings last quarter?
Option Care Health released its earnings results on Mar 05, 2020. The company reported -$0.09 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.09.
Is Option Care Health overvalued?
According to Wall Street analysts Option Care Health’s price is currently Undervalued.
Does Option Care Health pay dividends?
Option Care Health does not currently pay dividends.
What is Option Care Health’s EPS estimate?
Option Care Health’s EPS estimate is 0.47.
How many shares outstanding does Option Care Health have?
Option Care Health has 158,732,710 shares outstanding.
What happened to Option Care Health’s price movement after its last earnings report?
Option Care Health reported an EPS of -$0.09 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -8.615%.
Which hedge fund is a major shareholder of Option Care Health?
Currently, no hedge funds are holding shares in OPCH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Option Care Health Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$37.00 (6.47% Upside)
$37.00 (6.47% Upside)
Blogger Sentiment
Bullish
OPCH Sentiment 67%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 486.4K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $987.2K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 1.1%
Last 30 Days ▲ 3.7%
Last 30 Days ▲ 3.7%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
25.36%
12-Months-Change
Fundamentals
Return on Equity
15.02%
Trailing 12-Months
Asset Growth
1.52%
Trailing 12-Months
Company Description
Option Care Health
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; infusion therapies for bleeding disorders; therapies that women need to survive and thrive through high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.
OPCH Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Option Care Health's earnings call showcased strong revenue growth and raised guidance, driven by expansion in infusion services and effective capital management. However, the impact of Stelara biosimilars and pressure on gross margins posed challenges.View all OPCH earnings summariesOPCH Stock 12 Month Forecast
Average Price Target
$37.00
▲(6.47% Upside)
Technical Analysis
Addus Homecare
―
Chemed
―
National Healthcare
―
Surgery Partners
―
Aveanna Healthcare Holdings
―
Ownership Overview
1.41% Insiders
38.40% Mutual Funds
25.95% Other Institutional Investors
7.26% Public Companies and
Individual Investors